financetom
ANIP
financetom
/
Healthcare
/
ANIP
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
ANI Pharmaceuticals, Inc.ANIP
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada.

It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations, including extended release and combination products.

The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products.

It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations.

ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Latest News >
Nip Group Insider Sold Shares Worth $442,030, According to a Recent SEC Filing
Nip Group Insider Sold Shares Worth $442,030, According to a Recent SEC Filing
Jul 2, 2026
06:16 AM EDT, 07/02/2026 (MT Newswires) -- Liwei Sun, Director, President, on June 30, 2026, sold 353,624 shares in Nip Group ( NIPG ) for $442,030. Following the Form 4 filing with the SEC, Sun has control over a total of 18,095,424 Class B1 ordinary shares of the company, with 18,095,424 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1966233/000149315226031618/xslF345X05/ownership.xml ...
HUTCHMED's Orpathys Wins Conditional China Approval for Advanced Gastric Cancer
HUTCHMED's Orpathys Wins Conditional China Approval for Advanced Gastric Cancer
Jul 2, 2026
06:16 AM EDT, 07/02/2026 (MT Newswires) -- Hutchmed ( HCM ) said Thursday China's National Medical Products Administration granted conditional approval to marketing application of its therapy, Orpathys, to treat certain patients with locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma. The company said the approval is based on a phase 2 study in which Orpathys achieved its primary...
Market Chatter: Toyota to Partly Compensate Suppliers Hurt by Cancellation of Lexus EV
Market Chatter: Toyota to Partly Compensate Suppliers Hurt by Cancellation of Lexus EV
Jul 2, 2026
06:09 AM EDT, 07/02/2026 (MT Newswires) -- Toyota Motor ( TM ) will partially cover losses worth tens of billions of yen for suppliers affected by its decision to cancel the development of an electric vehicle, Nikkei Asia reported Wednesday. The cancellation of Lexus' LF-ZC sedan has hurt the company's supply chain, with some suppliers likely facing losses of up...
Argentina power firm Genneia files for US IPO
Argentina power firm Genneia files for US IPO
Jul 2, 2026
July 2 (Reuters) - Argentine power producer Genneia filed for an initial public offering in the U.S. on Thursday. (Reporting by Arasu Kannagi Basil in Bengaluru; Editing by Joyjeet Das) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved